Centre for Human Psychopharmacology

The effects of prescription benzodiazepines and alcohol on driving

This project aims to evaluate the combined effect common prescription benzodiazepines and alcohol on driving performance and eye movements during driving.

You may be eligible to participate if you*:

  • Are aged 21 to 40 years
  • Are fluent in written and spoken English
  • Have normal or corrected-to-normal vision
  • Are a social drinker (> 2 alcoholic drinks on a single occasion)
  • Are a regular driver (> 4,000km/year) with a full driver’s licence (no P plates)
  • Have a Body Mass Index (BMI) between (18.5-29.9)
  • Have no history of drug or substance dependence or abuse, or current illicit drug abuse
  • Have no history of neurological conditions, or cardiac, endocrine, gastrointestinal, or bleeding disorders
  • Have no previous or currnt history of psychiatric conditions (except where free from depression or anxiety diagnosis and treatment for > 2 years)
  • Aren't pregnant, potentially pregnant, or lactating
  • Aren't taking medication (except for prophylactic antibiotics, contraceptive pill, etc.)

What does participation involve?

Participants will be asked to attend Swinburne University’s Centre for Human Psychopharmacology on five separate occasions: 1 screening session for maximum 1½ hours and 4 testing sessions, 1 week apart, for 3 hours each.

In each testing session you will receive one of: alprazolam (1mg) and alcohol (0.04% BAC), alprazolam and placebo, alcohol and placebo, or placebo only.

You will be reimbursed with a $50 Coles Myer voucher for your time and travel at the completion of each testing session.

If you are interested in participating, please fill in your details below and one of our team members will give you a call to discuss further.


Benzo Study Team

Fields marked with an * are mandatory.

Your details

  1. Security Code:

    Audio Version
    Reload Image